September 2, 2005

NYU Gets $105-Million Pledge From Medical-School Professor

By ERIN STROUT

A microbiologist at New York University who helped to develop a leading anti-inflammatory drug there has pledged at least $105-million to the institution.

Jan T. Vilcek, a professor in the School of Medicine, said he would donate a percentage of the royalties he earns from Remicade, a medication used to treat rheumatoid arthritis and Crohn's disease, among other inflammatory diseases. He and Junming Le, a fellow microbiologist at NYU, developed the antibody that is the basis for the

Digital or Print Subscription

Web Pass

Already have an account? Log In Now.